Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension (Q80013636)
Jump to navigation
Jump to search
scientific article published on 01 December 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension |
scientific article published on 01 December 2006 |
Statements
Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension (English)
Toshio Kushiro
Hiroshige Itakura
Yoshihisa Abo
Hiromi Gotou
Shinji Terao
Deborah L Keefe
1 December 2006